The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses
Journal of Affective Disorders · 2026-06 · 402 · 121310
DOI: 10.1016/j.jad.2026.121310 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Affective Disorders, 2026-06. Verfasst von Hana Ballum und 13 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. Electronic address: hana.ballum@mail.utoronto.ca. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Cognition, Cognitive Dysfunction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Extant studies indicate that type 2 diabetes mellitus (T2DM) is associated with decreased cognitive function and increased risk for dementia, notably Alzheimer's Disease (AD). Herein, we aimed to evaluate the effect of GLP-1 receptor agonists (RAs) on cognitive measures in persons with cognitive impairment and T2DM from available systematic reviews and meta-analyses. We conducted a literature search on Web of Science and MEDLINE from inception to July 15, 2025. Article screening and data extraction were conducted by three reviewers (H.B., C.D., S.L.). Nine meta-analyses examining the effect of GLP-1 RAs on cognitive function in adults with T2DM were included. Primary research studies examining race, sex, children, animals and neurodegenerative diseases other than AD were excluded. Nine systematic reviews and meta-analyses support that there is convergence and replication of findings insofar as data support the hypothesis that GLP-1 RAs are associated with a reduction in overall cognitive decline in adults with T2DM and dementia/AD. Various meta-analyses indicated that GLP-1 RAs had improved results on cognitive assessments (total learning; p = 0.039; p 0.05). More studies are needed to determine definitive clinical significance. We report that GLP-1 RAs positively affect cognitive function in AD patients with T2DM. However, their efficacy on disparate cognitive domains requires further replication in larger scale controlled clinical trials. • Cognition is negatively affected by type 2 diabetes, particularly Alzheimer's disease. • We aimed to determine the effects of GLP-1 RA's, on cognitive function. • We performed an extensive literature search to extract meta-analyses on the topic. • Found that GLP-1 RA's have a positive impact on Alzheimer's cognition • Further replication in larger clinical trials is needed to test accurate effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. Electronic address: hana.ballum@mail.utoronto.ca.
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. Electronic address: christine.dri@mail.utoronto.ca.
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. Electronic address: sonya.liao@mail.utoronto.ca.
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. Electronic address: mindy.yu@mail.utoronto.ca.
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toront…
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of To…
Zitieren
APA
Ballum, H., Dri, C., Liao, S., Yu, M., Le, G. H., Wong, S., Teopiz, K. M., Kwan, A. T. H., Ho, R., Choi, H., Rosenblat, J. D., Vinberg, M., K Y Lo, H., & McIntyre, R. S. (2026). The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses. Journal of Affective Disorders, 402, 121310. https://doi.org/10.1016/j.jad.2026.121310
Vancouver
Ballum H, Dri C, Liao S, Yu M, Le GH, Wong S, et al. The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses. Journal of Affective Disorders. 2026;402:121310. doi:10.1016/j.jad.2026.121310
BibTeX
@article{Ballum2026,
author = {Ballum, Hana and Dri, Christine and Liao, Sonya and Yu, Minyi and Le, Gia Han and Wong, Sabrina and Teopiz, Kayla M and Kwan, Angela T H and Ho, Roger and Choi, Hayun and Rosenblat, Joshua D and Vinberg, Maj and K Y Lo, Heidi and McIntyre, Roger S},
title = {The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses},
journal = {Journal of Affective Disorders},
year = {2026},
volume = {402},
pages = {121310},
doi = {10.1016/j.jad.2026.121310}
}
EUVIMED